Genmab — Marts 2021

[GeorgeBest]

14:13 @Bulder: men referencen til subcu kan jo være relateret til Mosunetuzumab, hvor vi har vist siden sidste efterår at Roche vil udvikle en subcu version

[Bulder]

Det kan være. Jeg ved ikke specifikt om glofi.

[E_L]

New smal trial - An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus (DARALUP) https://clinicaltrials.gov/ct2/show/NCT04810754?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody+OR+hexabody+OR+Teclistamab+OR+Amivantamab+OR+Talquetamab+OR+Epcoritamab+OR+DuoHexabody&lupd_s=03%2F23%2F2021&draw=2&rank=1

[E_L]

we had a few articles indicating Dara would work here and in september an article where this Berlin hospital announced they would start a trial

[Helge_LarsenPI-redaktør]

Q&A starter kl. 15,30.

[Solsen]

SLE er en oplagt indikation for dara, som man ikke forstår hvorfor JNJ ikke har angrebet.

[Solsen]

NBI nede med 2,5% og Genmab kun 1% ... positivt

[svak]

Hvor følger vi o&a - der er ikke noget under fanen?

[exitnu]

Her: https://www.proinvestor.com/chathistory/-133/qa-genmab-2021-03-23

[svak]

tak -
exitnu

[Solsen]

Hexa38 lyder super interessant på Q&A

[peter12]

Ja og han lyder optimistisk

[Mcjean]

Yep det eneste tidspunkt han havde sin "det kører bare" hat på:-)

[Solsen]

Jeg tvivler stærkt på at HALO skal involveres i hexacd38

[Solsen]

Hvad mon CT siger

[E_L]

IV offcourse for now

[E_L]

and then hope the dose they end up with is small enough to put it through in SC

[GeorgeBest]

Tak til Helge for at arrangere denne unike mulighed for interaction med JvdW

[E_L]

so I guess we learned there is a maximum to the time JNJ can think about HexaBody-CD38 , which is they 'can in theory wait for the clinical data from two clinical studies'

[E_L]

I don't understand why he didn't give us the Dara price hike; he did so the last 2 times? Maybe there was no hike... Has anyone seen it anywhere else?